More information: Charles B. Reilly et al, Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics, Frontiers in Molecular Biosciences (2025). DOI: 10.3389/fmolb.2025. ...

More information: Charles B. Reilly et al, Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics, Frontiers in Molecular Biosciences (2025). DOI: 10.3389/fmolb.2025. ...

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...

"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases," said Anil R ...

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a broad-spectrum drug that can target a range of coronaviruses using physics-driven modeling — a ...

"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases," said Anil R ...

Delayed initiation of broad-spectrum antibiotics was also favored among patients with no critical illness (win ratio, 1.06; P <.0001) but not among those with critical illness (win ratio, 1.02; P ...

"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases," said Anil R. Diwan, ...

"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases," said Anil R ...